Methods of obtaining minocycline microspheres and their uses in dental health care
DOI:
https://doi.org/10.35381/s.v.v6i2.2123Keywords:
Tooth Diseases, Tooth Abnormalities, Oral Health. (Source, DeCS).Abstract
Objective: To describe the methods of obtaining minocycline microspheres and to determine the degree of knowledge of the teachers of the Unidad de Atención Odontológica (UAO) Uniandes about how to obtain this drug. Method: Descriptive observational study. Results and conclusion: The teachers of Unidad de Atención Odontológica (UAO) Uniandes do not know about the methods of obtaining minocycline microspheres so 4 % use tetracycline in clinical practice, 93 % know about the adverse effects of tetracycline, 32 % do not know the mechanism of action of tetracycline, 96% are not aware of the pharmaceutical forms of minocycline marketed in Ecuador, 100% have not used extended release devices with minocycline microspheres, 96% do not know the methods of obtaining minocycline microspheres.
Downloads
References
Steinberg D, Friedman M. Sustained-release drug delivery of antimicrobials in controlling of supragingival oral biofilms. Expert Opin Drug Deliv. 2017;14(4):571-581. doi:10.1080/17425247.2016.1213239
Franca JR, De Luca MP, Ribeiro TG, et al. Propolis--based chitosan varnish: drug delivery, controlled release and antimicrobial activity against oral pathogen bacteria. BMC Complement Altern Med. 2014;14:478. Published 2014 Dec 12. doi:10.1186/1472-6882-14-478
Morejón García M, Salup Díaz R., Cué Brugueras M. Actualización en tetraciclinas [Update on tetracyclines]. Rev Cubana Farm [Internet]. 2003; 37(3): 1-1.
Alvo A. Conceptos básicos para el uso racional de antibióticos en otorrinolaringología [Basic concepts for the rational use of antibiotics in otorhinolaryngology]. Revista de otorrinolaringología y cirugía de cabeza y cuello. 2016; 76(1): p. 15-19.
Shao L, Yang Z, Liu Y, Xia X, Li S, Yang C. Surface structure tuning of BiOCl nanosheets by the sequential introduction of oxygen vacancies, PO43- and Ag+ for boosting photodegradation of tetracycline hydrochloride. Environ Res. 2021;197:111056. doi:10.1016/j.envres.2021.111056
Thaker M, Spanogiannopoulos P, Wright GD. The tetracycline resistome. Cell Mol Life Sci. 2010;67(3):419-431. doi:10.1007/s00018-009-0172-6
Hou J, Wang C, Mao D, Luo Y. The occurrence and fate of tetracyclines in two pharmaceutical wastewater treatment plants of Northern China. Environ Sci Pollut Res Int. 2016;23(2):1722-1731. doi:10.1007/s11356-015-5431-5
Singh S, Khanna D, Kalra S. Minocycline and Doxycycline: More Than Antibiotics. Curr Mol Pharmacol. 2021;14(6):1046-1065. doi:10.2174/1874467214666210210122628
Sánchez AR, Rogers RS 3rd, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol. 2004;43(10):709-715. doi:10.1111/j.1365-4632.2004.02108.x
Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2012;2012(8):CD002086. Published 2012 Aug 15. doi:10.1002/14651858.CD002086.pub2
Allen AD, Bassil AM, Berkoff DJ, Al Maliki M, Draeger RW, Weinhold PS. Minocycline microspheres did not significantly improve outcomes after collagenase injection of tendon. J Orthop. 2019;16(6):580-584. Published 2019 Jun 3. doi:10.1016/j.jor.2019.06.007
Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol. 2000;27(1):53-60. doi:10.1034/j.1600-051x.2000.027001053.x
Nakao R, Senpuku H, Ohnishi M, Takai H, Ogata Y. Effect of topical administration of propolis in chronic periodontitis. Odontology. 2020;108(4):704-714. doi:10.1007/s10266-020-00500-4
Zhang T, Qiu Y, Song J, et al. Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment. Drug Deliv. 2021;28(1):620-633. doi: 10.1080/10717544.2021.1902020
Haidar MK, Yamashita F, Hashida M. Minocycline Hydrochloride Controlled-release Microsphere Preparation Process Optimization Based on the Robust Design Method. Turk J Pharm Sci. 2021;18(6):752-760. doi:10.4274/tjps.galenos.2021.56492
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
